International Prognostic Scoring System

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Not to be confused with International Prostate Symptom Score.

The International Prognostic Scoring System (IPSS) is used by many doctors to help assess the severity of a patient's myelodysplastic syndrome (MDS). Based on the IPSS score, the patient's history, and his/her personal observations, the physician will design a treatment plan to address the MDS.

The IPSS uses three "prognostic indicators" to develop a "score" which may be useful in understanding how the MDS may progress:

Each indicator is rated according to its severity and the ratings are combined into a "score."

Scores are sorted into one of four risk categories:

  • low
  • intermediate-1
  • intermediate-2
  • high

The two lower categories can be further described as the lower risk group while the two upper categories can be further described as the higher risk group.[1]

References[edit]